1. Home
  2. IVA vs API Comparison

IVA vs API Comparison

Compare IVA & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • API
  • Stock Information
  • Founded
  • IVA 2011
  • API 2013
  • Country
  • IVA France
  • API United States
  • Employees
  • IVA N/A
  • API N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • API Computer Software: Prepackaged Software
  • Sector
  • IVA Health Care
  • API Technology
  • Exchange
  • IVA Nasdaq
  • API Nasdaq
  • Market Cap
  • IVA 359.6M
  • API 354.4M
  • IPO Year
  • IVA 2020
  • API 2020
  • Fundamental
  • Price
  • IVA $3.07
  • API $3.76
  • Analyst Decision
  • IVA Strong Buy
  • API Strong Buy
  • Analyst Count
  • IVA 4
  • API 1
  • Target Price
  • IVA $10.50
  • API $6.00
  • AVG Volume (30 Days)
  • IVA 27.3K
  • API 434.1K
  • Earning Date
  • IVA 03-26-2025
  • API 08-18-2025
  • Dividend Yield
  • IVA N/A
  • API N/A
  • EPS Growth
  • IVA N/A
  • API N/A
  • EPS
  • IVA N/A
  • API N/A
  • Revenue
  • IVA $14,591,573.00
  • API $133,504,000.00
  • Revenue This Year
  • IVA $15.38
  • API $7.10
  • Revenue Next Year
  • IVA $24.22
  • API $10.91
  • P/E Ratio
  • IVA N/A
  • API N/A
  • Revenue Growth
  • IVA N/A
  • API N/A
  • 52 Week Low
  • IVA $1.53
  • API $1.65
  • 52 Week High
  • IVA $4.05
  • API $6.99
  • Technical
  • Relative Strength Index (RSI)
  • IVA 39.40
  • API 52.32
  • Support Level
  • IVA $3.25
  • API $3.53
  • Resistance Level
  • IVA $3.47
  • API $3.84
  • Average True Range (ATR)
  • IVA 0.23
  • API 0.14
  • MACD
  • IVA -0.04
  • API -0.02
  • Stochastic Oscillator
  • IVA 8.51
  • API 42.59

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About API Agora Inc.

Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.

Share on Social Networks: